A recent Medgadget article discussed a new type of vaccine that doesn’t require cold chain for transport. The vaccine, which was developed by researchers at the University of Queensland and Vaxxas, comes via a high-density microarray patch for a minimally invasive delivery without the use of needles. However, the most impressive part is the formulation’s stability; it can be stored for a month at room temperature, and a week at 104 degrees Fahrenheit. A video with more information can be seen here.
This COVID-19 Vaccine Doesn’t Require Cold Chain
The microarray patch vaccine can be stored for a month at room temperature and remain effective.
Nov 11, 2021
Recommended
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
